Actively Recruiting
At-home Breast Oncology Care Delivered With E-health Solutions
Led by University Health Network, Toronto · Updated on 2025-04-16
200
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The COVID-19 pandemic has significantly impacted healthcare service delivery, highlighting the need for high quality virtual patient care. Our team has developed a multi-dimensional remote eHealth solution for newly diagnosed breast cancer patients and their practitioners to use during the diagnostic and follow-up period. The ABODE study involved development of a Breast Cancer Treatment Application (app) which will facilitate virtual consultations, deliver patient education material, and collect patient reported outcome measures (PROMs). Using a randomized controlled trial design, the team will evaluate a variety of outcomes for breast cancer patients who will use the app throughout their diagnosis and treatment period. Primary Objective: To compare changes in patient activation (assessed by PAM-13) over 1 year among newly diagnosed breast cancer patients between those using the app and those receiving standard care. Secondary Objectives: 1. Compare additional PROMs between the standard care and intervention groups 2. Describe health service outcomes among app users 3. Explore end-user experience of using the app 4. Measure activity levels using wearable devices
CONDITIONS
Official Title
At-home Breast Oncology Care Delivered With E-health Solutions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Females (assigned female at birth)
- Diagnosed with first, primary invasive breast cancer
- Must have surgery as their first step in treatment pathway
- Age 18 years or older
- Access to an electronic device with internet connection
- Have a valid email address
- Can communicate in English
You will not qualify if you...
- Males (assigned male at birth)
- Diagnosed with non-operable breast cancer
- Stage 4 or metastatic breast cancer at diagnosis or during surgery
- Hearing or visual challenges
- Receiving neo-adjuvant chemotherapy
- Enrolled in another UHN study using an e-Health application
- Breast cancer surgery scheduled less than 5 business days after enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tulin Cil
Toronto, Ontario, Canada, M5G2M9
Actively Recruiting
Research Team
T
Tulin Cil, MD, MEd
CONTACT
E
Emma Reel, MSW
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here